(CIDRAP News) – Three new cases yesterday, with two deaths, increased a cluster of novel coronavirus (nCoV) cases in eastern Saudi Arabia to 13, and authorities confirmed that the illnesses are associated with a healthcare facility.
Saudi Arabian officials and the World Health Organization (WHO) reported three more novel coronavirus (nCoV) cases today in the same area of Saudi Arabia as seven cases reported yesterday, raising worries about possible person-to-person transmission.
(CIDRAP News) – It's been more or less an article of faith that influenza vaccination in the fall will protect a person through the winter flu season, but three studies published today in Eurosurveillance are challenging that view.
(CIDRAP News) – The type of flu transmission occurring mainly in young people directly exposed to pigs at fairs this summer is unprecedented, and health officials should consider keeping pigs away from the events, according to one infectious disease expert who has gone on record with his concerns.
(CIDRAP News) Questions abounded today concerning the large and growing outbreak of Escherichia coli infections concentrated in northern Germany, including where it came from, why it is striking mostly women, and why the number of reported hemolytic uremic syndrome (HUS) cases, at 276, is so unusually high.
(CIDRAP News) A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.
(CIDRAP News) A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.